十二指肠乳头旁憩室对ERCP手术治疗胆总管结石患者效果的影响*

doi:10.3969/j.issn.1672-5069.2021.06.038

摘要/Abstract

摘要： 目的分析十二指肠乳头旁憩室(PAD)对内镜下逆行胰胆管造影术(ERCP)治疗胆总管结石患者手术的影响。方法 2016年12月～2019年12月我院消化内科诊治的胆总管结石合并PAD患者101例(憩室内乳头37例,非憩室内乳头64例)和胆总管结石患者174例。所有患者在ERCP下插管、取石治疗。结果憩室组和非憩室组插管成功率分别为95.1%和98.4%,取石成功率分别为91.1%和92.0%,差异无统计学意义(P>0.05);术后,憩室组与非憩室组并发症发生率为19.8%和19.0%,差异无统计学意义(P>0.05);憩室内乳头组插管成功率为86.5%,取石成功率为81.1%,均显著低于非憩室内乳头组的100.0%和96.9%(P<0.05);术后,憩室内乳头组与非憩室内乳头组并发症发生率分别为24.3%和17.2%,差异无统计学意义(P>0.05)。结论 PAD会对ERCP手术治疗胆总管结石患者的效果产生一定的不利影响,尤其是憩室内乳头会增加插管难度,降低取石成功率,需要医生提高手术技巧,才能获得手术的成功。

关键词: 胆总管结石, 十二指肠乳头旁憩室, 内镜下逆行胰胆管造影术, 治疗

Abstract: Objective The aim of this study was to analyze the impact of periampullary diverticula (PAD) on surgical efficacy of endoscopic retrograde cholangiopancreatography (ERCP) in dealing with patients with choledocholithiasis. Methods A total of 275 patients with choledocholithiasis were admitted to our hospital between December 2016 and December 2019, and the presence of PAD were found in 101 patients, a papillary diverticulum in 37 cases and non-papillary diverticulum in 64 cases. All patients underwent ERCP for removal of stones. Results The success rates of intubation in patients with PAD and without PAD were 95.1% and 98.4%, respectively, and the success rates of stone removal in the two groups were 91.1% and 92.0%, respectively (P>0.05); the total incidence rate of postoperative complications was 19.8% in patients with and was 19.0% in patients without PAD (P>0.05); the success rate of intubation and success rate of stone removal in patients with papillary diverticulum were significantly lower than those with non-papillary diverticulum (86.5% vs. 100.0% and 81.1% vs. 96.9%, respectively, P<0.05); the total incidence rate of postoperative complications in patients with papillary diverticulum was 24.3%, not significantly different compared to 17.2% in patients with non-papillary diverticulum (P>0.05). Conclusion PAD has a certain influence on surgical intubation of ERCP for treatment of patients with choledocholithiasis, especially in those with papillary diverticulum, which could increase the difficulty of intubation and reduce the success rate of stone removal. The clinicians should practice for it as proficiently as possible.

Key words: Choledocholithiasis, Periampullary diverticula, Endoscopic retrograde cholangiopancreatography, Therapy

蔡创, 范若英, 李伟, 吴胜, 田宇剑, 唐晓明, 金勇, 周城臣. 十二指肠乳头旁憩室对ERCP手术治疗胆总管结石患者效果的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 919-922.

Cai Chuang, Fan Ruoying, Li Wei, et al. Impact of periampullary diverticula on surgical efficacy of ERCP in dealing with patients with choledocholithiasis[J]. Journal of Practical Hepatology, 2021, 24(6): 919-922.

参考文献

[1] 刘文博,建业,保积武. ERCP和EST治疗胆总管结石复发危险因素分析.实用肝脏病杂志,2019,22(3):140-143.
[2] Jayaraj M, Mohan BP, Dhindsa BS, et al. Periampullarydiverticula and ERCP outcomes: A systematic review and Meta-analysis. Dig Dis Sci, 2019, 64(5):1364-1376.
[3] Bruno M, Ribaldone DG, Fasulo R, et al. Is there a link between periampullary diverticula and biliopancreatic disease? An EUS approach to answer the question. Dig Liver Dis, 2018, 50(9):925-930.
[4] 陈圣雄,金成,郝子佳,等.内镜下柱状球囊扩张取石治疗十二指肠乳头旁憩室合并胆总管结石.中华肝胆外科杂志,2019,25(4):264-267.
[5] Peng L, Cheng X, Zhang L. Risk factors of stone recurrence after endoscopic retrograde cholangiopancreatography for common bile duct stones. Medicine (Baltimore). 2020, 99(27):20412-20417.
[6] 中华医学会外科学分会胆道外科学组.肝胆管结石病诊断治疗指南.中华消化外科杂志,2007,7(2):156-160.
[7] Mu P, Yue P,Li F, et al. Does periampullary diverticulum affect ERCP cannulation and post-procedure complications? an up-to-date meta-analysis. Turk J Gastroenterol, 2020, 31(3):193-204.
[8] Örmeci N, Deda X, Kalkan Ç, et al. Impact ofperiampullary diverticula on bile duct stones and ampullary carcinoma. Euroasian J Hepatogastroenterol, 2016, 6(1):31-34.
[9] Major P, Dembiński M, Winiarski M, et al. Aperiampullary duodenal diverticula in patient with choledocholithiasis-single endoscopic center experience. Pol Przegl Chir, 2016, 88(6):328-333.
[10] Coman IS, Radu EV, andru V, et al. Retainedcommon bile duct lithiasis at a patient with periampullary duodenal diverticulum. Chirurgia (Bucur), 2016, 111(6):517-521.
[11] Tabak F, Ji GZ, Miao L. Impact of periampullary diverticulum on biliary cannulation and ERCP outcomes: a single-center experience. Surg Endosc, 2020, 20(1):1-9.
[12] Han J. Presence ofperiampullary diverticulum is not a hurdle to successful endoscopic retrograde cholangiopancreatography. Clin Endosc, 2019, 52(1):7-8.
[13] 曹占国, 李宁, 王震宇, 等. 内镜逆行胆胰管造影术在胆总管结石合并壶腹部憩室中的应用. 中华消化内镜杂志, 2018, 35(7):503-506.
[14] Ketwaroo G, Qureshi W. ERCPsuccess rate and periampullary diverticula: The pocket makes no difference. Dig Dis Sci, 2019, 64(5):1072-1073.
[15] Parlak E, Suna N, Kuzu UB,et al. Diverticulum with papillae: Does position of papilla affect technical success? Surg Laparosc Endosc Percutan Tech, 2015, 25(5):395-398.
[16] 于天宇,吴硕东,韩金岩.十二指肠乳头旁憩室与胆胰疾病的关系及对内镜诊疗的影响.中华消化内镜杂志,2019,36(6):422-426.
[17] Zimmer V, Lammert F. Periampullary choledochal diverticulum. Clin Res Hepatol Gastroenterol, 2020, 44(5):628-629.
[18] Ozogul B, Ozturk G, Kisaoglu A,et al. The clinical importance of different localizations of the papilla associated with juxtapapillary duodenal diverticula. Can J Surg, 2014, 57(5):337-341.
[19] Karaahmet F, Kekilli M. The presence of periampullary diverticulum increased the complications of endoscopic retrograde cholangiopancreatography. Eur J Gastroenterol Hepatol, 2018, 30(9):1009-1012.
[20] Xu XD, Xu CF, Qian JQ, et al. Endoscopic papillary large balloon dilation with minor sphincterotomy for periampullary diverticular papilla. Rev Esp Enferm Dig, 2019, 111(12):935-940.

十二指肠乳头旁憩室对ERCP手术治疗胆总管结石患者效果的影响^*

Impact of periampullary diverticula on surgical efficacy of ERCP in dealing with patients with choledocholithiasis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	汤磊, 邹桂舟. 外科疾病导致的胆源性肝损伤诊治现状[J]. 实用肝脏病杂志, 2021, 24(6): 769-771.
[2]	姜浩, 张雯, 陈霞. 长效干扰素联合利巴韦林治疗慢性丙型肝炎患者疗效及其对静息能量消耗和营养状态的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 815-818.
[3]	黄飞虎, 薛建亚, 朱咏梅, 余姣, 王丽艳, 鲁琼. 应用索磷布韦/维帕他韦治疗门诊和住院筛查的丙型肝炎患者疗效研究[J]. 实用肝脏病杂志, 2021, 24(6): 819-822.
[4]	肖金玉, 王延峰, 文小霞. 自身免疫性肝炎患者血清趋化因子CCL4和CXCL10水平及其临床意义探讨[J]. 实用肝脏病杂志, 2021, 24(6): 827-830.
[5]	杜云飞, 刘景瑞, 叶飞翔. N-乙酰半胱氨酸联合双环醇治疗抗结核药物所致的药物性肝损伤患者疗效研究^*[J]. 实用肝脏病杂志, 2021, 24(6): 847-850.
[6]	刘玉玲, 甄增国, 王慧娟, 万秀敏, 郭振凯. 益生菌制剂对肝硬化并发自发性细菌性腹膜炎患者肠道屏障功能的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 867-870.
[7]	黄力鸥, 吴春荣, 徐丹, 崔宇慧, 唐建国. 无肝素化连续性肾脏替代治疗肝硬化并发肝性脑病患者疗效研究^*[J]. 实用肝脏病杂志, 2021, 24(6): 875-878.
[8]	王菁, 毕宁, 方亮, 田园. 自体骨髓干细胞经肝动脉肝内移植治疗失代偿期乙型肝炎肝硬化患者疗效研究[J]. 实用肝脏病杂志, 2021, 24(6): 887-890.
[9]	束青华, 张楠楠, 葛勇胜. 不同HCV基因型感染的慢性丙型肝炎和肝硬化患者对重组人干扰素α-2a治疗应答的影响[J]. 实用肝脏病杂志, 2021, 24(6): 899-902.
[10]	俞士刚, 田佳, 吴铁, 樊书荣. 损伤控制性手术对创伤性肝破裂患者生存及相关应激指标的影响^*[J]. 实用肝脏病杂志, 2021, 24(6): 915-918.
[11]	梁晨, 郑素军. Wilson病治疗研究现状^*[J]. 实用肝脏病杂志, 2021, 24(6): 930-933.
[12]	李伟之, 李培杰, 马富权, 刘梦莹, 薛挥. 应用利伐沙班抗凝治疗经皮血管内介入治疗的布加综合征患者疗效和安全性研究^*[J]. 实用肝脏病杂志, 2021, 24(5): 621-624.
[13]	李伟, 宋卫东, 谢巴图白音. 采用EVL或TIPS治疗肝硬化并发食管静脉曲张出血患者疗效及其预后分析^*[J]. 实用肝脏病杂志, 2021, 24(5): 629-632.
[14]	季旻游, 李超, 赵兴忠, 武煦峰. 恩替卡韦联合复方甘草酸苷治疗乙型肝炎肝硬化患者疗效及对肠道菌群的影响^*[J]. 实用肝脏病杂志, 2021, 24(5): 641-644.
[15]	刘公伟, 吴雪, 唐聃, 敖宇, 陈景祥, 蔡治方. 脾切除联合门奇静脉断流术治疗乙型肝炎肝硬化门脉高压症患者疗效研究^*[J]. 实用肝脏病杂志, 2021, 24(5): 649-652.